Glucosamine sulfate: the first clinical proven disease modifying drug for osteoarthritis / 中国新药与临床杂志

ABSTRACT

The publish summarized three latest systemic reviews and given details of the landmark trail on glucosamine sulfate introduce the yesterday, today and a good future of disease modifying drug for osteoarthritis (DMOAD) on a view. It will helpful to promote the clinical, the assessment and the developing of DMOAD in China.